All Pharma News
CENTOGENE Receives Nasdaq Non-Compliance Notice

CENTOGENE Receives Nasdaq Non-Compliance Notice
GLOBENEWSWIRE
02 Apr 2024
Share Share
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing
GLOBENEWSWIRE
19 Mar 2024
Share Share
CENTOGENE Explores Strategic Alternatives

CENTOGENE Explores Strategic Alternatives
GLOBENEWSWIRE
28 Feb 2024
Share Share
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting

CENTOGENE Announces Receipt of Nasdaq Notice of Delisting
GLOBENEWSWIRE
28 Feb 2024
Share Share
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
GLOBENEWSWIRE
25 Jan 2024
Share Share
CENTOGENE Receives French Research Tax Credit Accreditation

CENTOGENE Receives French Research Tax Credit Accreditation
GLOBENEWSWIRE
24 Jan 2024
Share Share
CENTOGENE and The Michael J. Fox Foundation Announce Research Project

CENTOGENE and The Michael J. Fox Foundation Announce Research Project
GLOBENEWSWIRE
23 Jan 2024
Share Share
CENTOGENE Announces Preliminary Full Year 2023 Revenue

CENTOGENE Announces Preliminary Full Year 2023 Revenue
GLOBENEWSWIRE
18 Jan 2024
Share Share
CENTOGENE Announces Voting Results of Extraordinary General Meeting

CENTOGENE Announces Voting Results of Extraordinary General Meeting
GLOBENEWSWIRE
19 Dec 2023
Share Share
CENTOGENE™s FTD Genetic Study, EFRONT, Reaches Patient Enrollment Milestone

CENTOGENE™s FTD Genetic Study, EFRONT, Reaches Patient Enrollment Milestone
GLOBENEWSWIRE
13 Dec 2023
Share Share